SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?


To: robert miller who wrote (1666)9/16/1998 11:36:00 PM
From: John Arnopp  Respond to of 4467
 
bob, Rick, and s.l.,

I agree. If anything, Safeguard has been buying in this slump (which we have hopefully seen the bottom of, except for Safeguard itself, which I expect to hit about 25-1/2 before bouncing back).

Everyone else has done a great job answering Rick's questions. As far as owning Safeguard, any time yo can get it for NAV or a discount to public co.'s, it's a buy, IMHO. At a premium, there has to be a reason, such as a rights offering coming up (though you don't always see it) or favorable outlook for their business/holdings.

Lately, the rights offering companies have been doing poorly, and actually would be subtracting from a shareholder's gain (a negative dividend) even though they are adding NAV to Safeguard itself (since shareholder's pay $1 for the new company for every SFE share they own, and Safeguard's price is often less than this). OAOT and DOCC have been trading in the $0.60 per share range lately. Not fun. In good times, the private portfolio can add $10 in real value to NAV.

--John



To: robert miller who wrote (1666)9/17/1998 8:39:00 AM
From: Bryan Steffen  Respond to of 4467
 
In fact I would be willing to bet that SFE is not allowed to sell any TLAB for a period of about 6 months after they got the stock.